Table of Content

1 Peroxisome Proliferator Activated Receptor Delta Market Overview
1.1 Product Overview and Scope of Peroxisome Proliferator Activated Receptor Delta
1.2 Peroxisome Proliferator Activated Receptor Delta Segment by Type
1.2.1 Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2024-2034)
1.2.2 MTB-2
1.2.3 HPP-593
1.2.4 CNX-013B2
1.2.5 CS-038
1.2.6 MA-0204
1.2.7 Others
1.3 Peroxisome Proliferator Activated Receptor Delta Segment by Application
1.3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Value by Application: (2024-2034)
1.3.2 Bone Disorders
1.3.3 Colitis
1.3.4 Obesity
1.3.5 Osteoporosis
1.3.6 Others
1.4 Global Peroxisome Proliferator Activated Receptor Delta Market Size Estimates and Forecasts
1.4.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue 2018-2034
1.4.2 Global Peroxisome Proliferator Activated Receptor Delta Sales 2018-2034
1.4.3 Global Peroxisome Proliferator Activated Receptor Delta Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Peroxisome Proliferator Activated Receptor Delta Market Competition by Manufacturers
2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Manufacturers (2018-2024)
2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Peroxisome Proliferator Activated Receptor Delta Average Price by Manufacturers (2018-2024)
2.4 Global Peroxisome Proliferator Activated Receptor Delta Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Product Type & Application
2.7 Peroxisome Proliferator Activated Receptor Delta Market Competitive Situation and Trends
2.7.1 Peroxisome Proliferator Activated Receptor Delta Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peroxisome Proliferator Activated Receptor Delta Players Market Share by Revenue
2.7.3 Global Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peroxisome Proliferator Activated Receptor Delta Retrospective Market Scenario by Region
3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Peroxisome Proliferator Activated Receptor Delta Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2018-2034
3.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2018-2024
3.2.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2024-2034
3.3 Global Peroxisome Proliferator Activated Receptor Delta Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2018-2034
3.3.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2018-2024
3.3.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2024-2034
3.4 North America Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.4.1 North America Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2034)
3.4.3 North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.5.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2034)
3.5.3 Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.6.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2034)
3.6.3 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.7.1 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2034)
3.7.3 Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.8.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2034)
3.8.3 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2034)
4.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024)
4.1.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2024-2034)
4.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2018-2034)
4.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2018-2034)
4.2.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2018-2024)
4.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2024-2034)
4.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2018-2034)
4.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2018-2034)
5 Segment by Application
5.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2034)
5.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024)
5.1.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2024-2034)
5.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2018-2034)
5.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2018-2034)
5.2.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2018-2024)
5.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2024-2034)
5.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2018-2034)
5.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Chipscreen Biosciences Ltd
6.1.1 Chipscreen Biosciences Ltd Corporation Information
6.1.2 Chipscreen Biosciences Ltd Description and Business Overview
6.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.1.5 Chipscreen Biosciences Ltd Recent Developments/Updates
6.2 Connexios Life Sciences Pvt Ltd
6.2.1 Connexios Life Sciences Pvt Ltd Corporation Information
6.2.2 Connexios Life Sciences Pvt Ltd Description and Business Overview
6.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.2.5 Connexios Life Sciences Pvt Ltd Recent Developments/Updates
6.3 CymaBay Therapeutics Inc
6.3.1 CymaBay Therapeutics Inc Corporation Information
6.3.2 CymaBay Therapeutics Inc Description and Business Overview
6.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.3.5 CymaBay Therapeutics Inc Recent Developments/Updates
6.4 Genfit SA
6.4.1 Genfit SA Corporation Information
6.4.2 Genfit SA Description and Business Overview
6.4.3 Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Genfit SA Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.4.5 Genfit SA Recent Developments/Updates
6.5 Inventiva
6.5.1 Inventiva Corporation Information
6.5.2 Inventiva Description and Business Overview
6.5.3 Inventiva Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Inventiva Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.5.5 Inventiva Recent Developments/Updates
6.6 Mitobridge Inc
6.6.1 Mitobridge Inc Corporation Information
6.6.2 Mitobridge Inc Description and Business Overview
6.6.3 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.6.5 Mitobridge Inc Recent Developments/Updates
6.7 Nippon Chemiphar Co Ltd
6.6.1 Nippon Chemiphar Co Ltd Corporation Information
6.6.2 Nippon Chemiphar Co Ltd Description and Business Overview
6.6.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.7.5 Nippon Chemiphar Co Ltd Recent Developments/Updates
6.8 Senju Pharmaceutical Co Ltd
6.8.1 Senju Pharmaceutical Co Ltd Corporation Information
6.8.2 Senju Pharmaceutical Co Ltd Description and Business Overview
6.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.8.5 Senju Pharmaceutical Co Ltd Recent Developments/Updates
6.9 T3D Therapeutics Inc
6.9.1 T3D Therapeutics Inc Corporation Information
6.9.2 T3D Therapeutics Inc Description and Business Overview
6.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
6.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.9.5 T3D Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peroxisome Proliferator Activated Receptor Delta Industry Chain Analysis
7.2 Peroxisome Proliferator Activated Receptor Delta Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peroxisome Proliferator Activated Receptor Delta Production Mode & Process
7.4 Peroxisome Proliferator Activated Receptor Delta Sales and Marketing
7.4.1 Peroxisome Proliferator Activated Receptor Delta Sales Channels
7.4.2 Peroxisome Proliferator Activated Receptor Delta Distributors
7.5 Peroxisome Proliferator Activated Receptor Delta Customers
8 Peroxisome Proliferator Activated Receptor Delta Market Dynamics
8.1 Peroxisome Proliferator Activated Receptor Delta Industry Trends
8.2 Peroxisome Proliferator Activated Receptor Delta Market Drivers
8.3 Peroxisome Proliferator Activated Receptor Delta Market Challenges
8.4 Peroxisome Proliferator Activated Receptor Delta Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Peroxisome Proliferator Activated Receptor Delta Market Competitive Situation by Manufacturers in 2022
Table 4. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Peroxisome Proliferator Activated Receptor Delta Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Peroxisome Proliferator Activated Receptor Delta, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Product Type & Application
Table 12. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peroxisome Proliferator Activated Receptor Delta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2018-2024)
Table 19. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2024-2034)
Table 21. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2018-2024)
Table 23. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2024-2034)
Table 25. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2018-2024)
Table 51. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2024-2034)
Table 52. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2018-2024)
Table 53. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2024-2034)
Table 54. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2018-2024)
Table 57. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2024-2034)
Table 58. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2018-2024)
Table 61. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2024-2034)
Table 62. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2018-2024)
Table 63. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2024-2034)
Table 64. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2018-2024)
Table 67. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2024-2034)
Table 68. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2024-2034)
Table 70. Chipscreen Biosciences Ltd Corporation Information
Table 71. Chipscreen Biosciences Ltd Description and Business Overview
Table 72. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 74. Chipscreen Biosciences Ltd Recent Developments/Updates
Table 75. Connexios Life Sciences Pvt Ltd Corporation Information
Table 76. Connexios Life Sciences Pvt Ltd Description and Business Overview
Table 77. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 79. Connexios Life Sciences Pvt Ltd Recent Developments/Updates
Table 80. CymaBay Therapeutics Inc Corporation Information
Table 81. CymaBay Therapeutics Inc Description and Business Overview
Table 82. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 84. CymaBay Therapeutics Inc Recent Developments/Updates
Table 85. Genfit SA Corporation Information
Table 86. Genfit SA Description and Business Overview
Table 87. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Genfit SA Peroxisome Proliferator Activated Receptor Delta Product
Table 89. Genfit SA Recent Developments/Updates
Table 90. Inventiva Corporation Information
Table 91. Inventiva Description and Business Overview
Table 92. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Inventiva Peroxisome Proliferator Activated Receptor Delta Product
Table 94. Inventiva Recent Developments/Updates
Table 95. Mitobridge Inc Corporation Information
Table 96. Mitobridge Inc Description and Business Overview
Table 97. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 99. Mitobridge Inc Recent Developments/Updates
Table 100. Nippon Chemiphar Co Ltd Corporation Information
Table 101. Nippon Chemiphar Co Ltd Description and Business Overview
Table 102. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 104. Nippon Chemiphar Co Ltd Recent Developments/Updates
Table 105. Senju Pharmaceutical Co Ltd Corporation Information
Table 106. Senju Pharmaceutical Co Ltd Description and Business Overview
Table 107. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 109. Senju Pharmaceutical Co Ltd Recent Developments/Updates
Table 110. T3D Therapeutics Inc Corporation Information
Table 111. T3D Therapeutics Inc Description and Business Overview
Table 112. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 114. T3D Therapeutics Inc Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Peroxisome Proliferator Activated Receptor Delta Distributors List
Table 118. Peroxisome Proliferator Activated Receptor Delta Customers List
Table 119. Peroxisome Proliferator Activated Receptor Delta Market Trends
Table 120. Peroxisome Proliferator Activated Receptor Delta Market Drivers
Table 121. Peroxisome Proliferator Activated Receptor Delta Market Challenges
Table 122. Peroxisome Proliferator Activated Receptor Delta Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peroxisome Proliferator Activated Receptor Delta
Figure 2. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Type in 2022 & 2034
Figure 4. MTB-2 Product Picture
Figure 5. HPP-593 Product Picture
Figure 6. CNX-013B2 Product Picture
Figure 7. CS-038 Product Picture
Figure 8. MA-0204 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Application in 2022 & 2034
Figure 12. Bone Disorders
Figure 13. Colitis
Figure 14. Obesity
Figure 15. Osteoporosis
Figure 16. Others
Figure 17. Global Peroxisome Proliferator Activated Receptor Delta Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Peroxisome Proliferator Activated Receptor Delta Market Size (2018-2034) & (US$ Million)
Figure 19. Global Peroxisome Proliferator Activated Receptor Delta Sales (2018-2034) & (K Pcs)
Figure 20. Global Peroxisome Proliferator Activated Receptor Delta Average Price (USD/Pcs) & (2018-2034)
Figure 21. Peroxisome Proliferator Activated Receptor Delta Report Years Considered
Figure 22. Peroxisome Proliferator Activated Receptor Delta Sales Share by Manufacturers in 2022
Figure 23. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Peroxisome Proliferator Activated Receptor Delta Players: Market Share by Revenue in 2022
Figure 25. Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 27. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2018-2034)
Figure 28. North America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2018-2034)
Figure 29. U.S. Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2018-2034)
Figure 32. Europe Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2018-2034)
Figure 33. Germany Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2018-2034)
Figure 40. China Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2018-2034)
Figure 51. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Peroxisome Proliferator Activated Receptor Delta by Type (2018-2034)
Figure 61. Global Revenue Market Share of Peroxisome Proliferator Activated Receptor Delta by Type (2018-2034)
Figure 62. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2018-2034)
Figure 63. Global Sales Market Share of Peroxisome Proliferator Activated Receptor Delta by Application (2018-2034)
Figure 64. Global Revenue Market Share of Peroxisome Proliferator Activated Receptor Delta by Application (2018-2034)
Figure 65. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2018-2034)
Figure 66. Peroxisome Proliferator Activated Receptor Delta Value Chain
Figure 67. Peroxisome Proliferator Activated Receptor Delta Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed